These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22531340)

  • 1. AZD-3043: a novel, metabolically labile sedative-hypnotic agent with rapid and predictable emergence from hypnosis.
    Egan TD; Obara S; Jenkins TE; Jaw-Tsai SS; Amagasu S; Cook DR; Steffensen SC; Beattie DT
    Anesthesiology; 2012 Jun; 116(6):1267-77. PubMed ID: 22531340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS 7056: a novel ultra-short-acting Benzodiazepine.
    Kilpatrick GJ; McIntyre MS; Cox RF; Stafford JA; Pacofsky GJ; Lovell GG; Wiard RP; Feldman PL; Collins H; Waszczak BL; Tilbrook GS
    Anesthesiology; 2007 Jul; 107(1):60-6. PubMed ID: 17585216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of fluorine-substituted phenyl acetate derivatives as ultra-short recovery sedative/hypnotic agents.
    Zhang H; Xu X; Chen Y; Qiu Y; Liu X; Liu BF; Zhang G
    PLoS One; 2014; 9(5):e96518. PubMed ID: 24796695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate.
    Pejo E; Cotten JF; Kelly EW; Le Ge R; Cuny GD; Laha JK; Liu J; Lin XJ; Raines DE
    Anesth Analg; 2012 Aug; 115(2):297-304. PubMed ID: 21965364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and evaluation of phenylpiperazine-phenylacetate derivatives as rapid recovery hypnotic agents.
    Qi Z; Li Z; Zhu M; Zhang X; Zhang G; Zhuang T; Chen Y; Huang L
    Bioorg Med Chem Lett; 2022 Feb; 57():128497. PubMed ID: 34896213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing novel anesthetics: pharmacodynamic and pharmacokinetic studies of cyclopropyl-methoxycarbonyl metomidate in dogs.
    Campagna JA; Pojasek K; Grayzel D; Randle J; Raines DE
    Anesthesiology; 2014 Dec; 121(6):1203-16. PubMed ID: 25170571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the electrophysiological and pharmacological effects of 4-iodo-2,6-diisopropylphenol, a propofol analogue devoid of sedative-anaesthetic properties.
    Sanna E; Motzo C; Usala M; Serra M; Dazzi L; Maciocco E; Trapani G; Latrofa A; Liso G; Biggio G
    Br J Pharmacol; 1999 Mar; 126(6):1444-54. PubMed ID: 10217539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First Human Study of the Investigational Sedative and Anesthetic Drug AZD3043: A Dose-Escalation Trial to Assess the Safety, Pharmacokinetics, and Efficacy of a 30-Minute Infusion in Healthy Male Volunteers.
    Kalman S; Koch P; Ahlén K; Kanes SJ; Barassin S; Björnsson MA; Norberg Å
    Anesth Analg; 2015 Oct; 121(4):885-893. PubMed ID: 26111262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LMR-101, a novel derivative of propofol, exhibits potent anticonvulsant effects and possibly interacts with a novel target on γ-aminobutyric acid type A receptors.
    Zhao Y; An L; Guo S; Huang X; Tian H; Liu L; Chen T; Sun X; Mei Q; Wang R
    Epilepsia; 2021 Jan; 62(1):238-249. PubMed ID: 33417274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous gamma-aminobutyric acid (GABA)(A) receptor active neurosteroids and the sedative/hypnotic action of gamma-hydroxybutyric acid (GHB): a study in GHB-S (sensitive) and GHB-R (resistant) rat lines.
    Barbaccia ML; Carai MA; Colombo G; Lobina C; Purdy RH; Gessa GL
    Neuropharmacology; 2005 Jul; 49(1):48-58. PubMed ID: 15992580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics and Pharmacokinetics of HSK3486, a Novel 2,6-Disubstituted Phenol Derivative as a General Anesthetic.
    Liao J; Li M; Huang C; Yu Y; Chen Y; Gan J; Xiao J; Xiang G; Ding X; Jiang R; Li P; Yang M
    Front Pharmacol; 2022; 13():830791. PubMed ID: 35185584
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerance to sedative/hypnotic actions of GABAergic drugs correlates with tolerance to potentiation of extrasynaptic tonic currents of alcohol-dependent rats.
    Liang J; Spigelman I; Olsen RW
    J Neurophysiol; 2009 Jul; 102(1):224-33. PubMed ID: 19420124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anesthetic properties of 4-iodopropofol: implications for mechanisms of anesthesia.
    Lingamaneni R; Krasowski MD; Jenkins A; Truong T; Giunta AL; Blackbeer J; MacIver MB; Harrison NL; Hemmings HC
    Anesthesiology; 2001 Jun; 94(6):1050-7. PubMed ID: 11465597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroencephalographic recovery, hypnotic emergence, and the effects of metabolite after continuous infusions of a rapidly metabolized etomidate analog in rats.
    Pejo E; Ge R; Banacos N; Cotten JF; Husain SS; Raines DE
    Anesthesiology; 2012 May; 116(5):1057-65. PubMed ID: 22417966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoliquiritigenin, a chalcone compound, is a positive allosteric modulator of GABAA receptors and shows hypnotic effects.
    Cho S; Kim S; Jin Z; Yang H; Han D; Baek NI; Jo J; Cho CW; Park JH; Shimizu M; Jin YH
    Biochem Biophys Res Commun; 2011 Oct; 413(4):637-42. PubMed ID: 21945440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methoxycarbonyl-etomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression.
    Cotten JF; Husain SS; Forman SA; Miller KW; Kelly EW; Nguyen HH; Raines DE
    Anesthesiology; 2009 Aug; 111(2):240-9. PubMed ID: 19625798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JM-1232(-) and propofol, a new combination of hypnotics with short-acting and non-cumulative preferable properties.
    Taharabaru S; Tamura T; Higashi M; Matsuda N; Satomoto M; Adachi YU; Sato AB; Okuda M
    Exp Anim; 2021 Feb; 70(1):101-107. PubMed ID: 33071272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABAA receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon.
    Wegner F; Deuther-Conrad W; Scheunemann M; Brust P; Fischer S; Hiller A; Diekers M; Strecker K; Wohlfarth K; Allgaier C; Steinbach J; Hoepping A
    Eur J Pharmacol; 2008 Feb; 580(1-2):1-11. PubMed ID: 18035350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
    Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic-pharmacodynamic modeling of the new steroid hypnotic eltanolone in healthy volunteers.
    Hering WJ; Ihmsen H; Langer H; Uhrlau C; Dinkel M; Geisslinger G; Schüttler J
    Anesthesiology; 1996 Dec; 85(6):1290-9. PubMed ID: 8968176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.